Clinical Trials Sponsored by Danube Hospital

Total 100656 results

Danone Asia Pacific Holdings Pte, Ltd.
Danone Research

Withdrawn

Colonisation Resistance Study (ColoR)

Healthy Infants

Thailand
Danone Specialized Nutrition

Recruiting

Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients

Cancer | Inflammatory Bowel Diseases | Malnutrition | Hiv | Chronic Obstructive Pulmonary Disease (COPD)

Spain
Danone Specialized Nutrition

Completed

Compliance With a High Energy Content, Low Volume Oral Nutritional Supplement

Malnutrition

Spain
Danube University Krems
University of Vienna; University of Innsbruck

Recruiting

The Effect of Increasing Physical Activity or Reducing Mobile Phone Use on Mental Health in Young People in Austria (SPARKY)

Mental Health Issue

Austria
Bispebjerg Hospital
University College Absalon; Danske Fysioterapeuter

Active, not recruiting

Blood Flow Restriction Training for Treatment of Chronic Patellar Tendinopathy

Jumper's Knee | Patellar Tendinopathy

Denmark
Danone Nutricia Research

Terminated

An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population

Mild and Moderate Alzheimer's Disease | Cognitively Healthy People

Singapore
Danone Institute International

Unknown

The Early Origins of Cardiovascular Disease

Cardiovascular Disease

France
Copenhagen University Hospital, Hvidovre
Velux Fonden; Danske Fysioterapeuter

Terminated

The WALK-Copenhagen Trial (WALK-Cph): a Mixed Methods Study

Hospitalization | Activity

Denmark
Brigham and Women's Hospital
Mitsubishi Tanabe Pharma Corporation

Completed

Heparin-Induced Thrombocytopenia Registry (HIT)

Heparin-Induced Thrombocytopenia

United States
Mitsubishi Tanabe Pharma America Inc.
Massachusetts General Hospital

Active, not recruiting

Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

Amyotrophic Lateral Sclerosis | ALS

United States, Canada
Danone Specialized Nutrition Indonesia

Recruiting

Tolerance of Extensive Hydrolyzed Whey Protein Milk Among Infant With Mild to Moderate CMPA (PEACE)

Mild to Moderate Cows' Milk Protein Allergy

Indonesia
Mitsubishi Tanabe Pharma Corporation

Recruiting

An Exploratory Study of MT-2990 in Patients With AAV

Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV)

Japan
Danone Research
Euraxi Pharma

Active, not recruiting

Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms

Gastro-intestinal Symptoms in Healthy Subjects

France
Mitsubishi Tanabe Pharma Corporation

Completed

Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube

Healthy Adult Subjects

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Hemodialysis Dependent Chronic Kidney Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Effects of Iron Supplements on the Pharmacokinetics of MT-6548

Healthy

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS

ALS

Japan
Enrollme.ru, LLC
Danone Nutricia

Completed

Study of the ONS "Nutrinidrink With Dietary Fiber" Use Effect on Some Health Indicators in Children With Cerebral Palsy

Cerebral Palsy

Russian Federation
Enrollme.ru, LLC
Danone Nutricia

Completed

Study to Assess the Effect of ONS Nutridrink® 200 ml on the Recovery of Patients With COVID-19 and Respiratory Support

COVID-19

Russian Federation
Enrollme.ru, LLC
Danone Nutricia

Completed

Study to Assess the Clinical Efficacy of the Specialized Enteral Tube Nutrition Composition Nutrison Advanced Cubison as a Part of Complex Pressure Ulcers (PU) Therapy

Pressure Ulcer ( Stage 2-3)

Russian Federation
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

Diabetic Nephropathy

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MP-214 in Patients With Schizophrenia

Schizophrenia

Taiwan, Korea, Republic of, Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease

Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

Painful Diabetic Peripheral Neuropathy

Germany, Hungary, Poland
Mitsubishi Tanabe Pharma Corporation

Completed

A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

Dermatitis | Atopic

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

Crohn's Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Extension Study of MT-1303 in Subjects With Crohn's Disease

Crohn's Disease

Czechia, France, Germany, Hungary, Israel, Italy, Japan, Netherlands, Poland, Slovakia, Ukraine
Mitsubishi Tanabe Pharma Corporation

Completed

Mass Balance Study of MT-3995

Healthy

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Chronic Hepatitis C (CHC)

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Dose-finding Study of MT-1303

Relapsing-remitting Multiple Sclerosis

Croatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Heparin-induced Thrombocytopenia Type II

France
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects

Healthy

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety and Tolerability Study of MCI-196

Chronic Kidney Disease | Hyperphosphatemia | Paediatric | Not on Dialysis

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Terminated

Dose-finding Study of MCI-196

Chronic Kidney Disease | Hyperphosphatemia | Dialysis | Paediatric

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

Comparative Oral Bioavailability Study of MT-1303

Relapsing-remitting Multiple Sclerosis

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

Mass Balance Study of MT-1303

Relapsing-remitting Multiple Sclerosis

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303

Relapsing-remitting Multiple Sclerosis

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria

Diabetic Nephropathy

Lithuania, Romania, Bulgaria, Hungary, Slovakia
Mitsubishi Tanabe Pharma Corporation

Completed

Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Bulgaria, Russian Federation, Estonia, Hungary, Latvia, Poland, Ukraine, Germany
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia

France, Poland, United Kingdom, Spain, South Africa, Australia, Czech Republic, Germany, Hungary, Italy, Austria
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia | Dialysis

France, Poland, Ukraine, United Kingdom, Spain, Serbia, South Africa, Russian Federation, Czech Republic, Germany, Hungary, Italy, Austria, Macedonia, The Former Yugoslav Republic of, Malaysia

Clinical Trials Sponsored by Danube Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations